Activity and safety of temozolomide in advanced adrenocortical carcinoma patients.
Cosentini D, Badalamenti G, Grisanti S, Basile V, Rapa I, Cerri S, Spallanzani A, Perotti P, Musso E, Laganà M, Ferrari VD, Luppi G, Dalla Volta A, Incorvaia L, Sigala S, Russo A, Volante M, Terzolo M, Berruti A.
Cosentini D, et al. Among authors: ferrari vd.
Eur J Endocrinol. 2019 Dec;181(6):681-689. doi: 10.1530/EJE-19-0570.
Eur J Endocrinol. 2019.
PMID: 31639772